TORONTO, April 22, 2025 — BioPharma Services Inc., a leading global Contract Research Organization (CRO), is pleased to announce the successful completion of a comprehensive Quality Inspection (QI) by Health Canada at its clinical research facility. The inspection was...
Toronto, ON, September 23 — BioPharma Services Inc., a leading Contract Research Organization (CRO), is proud to announce the successful completion of a GCP inspection by the FDA at our clinical facility. The weeklong audit concluded with no Form 483 issued. This...
HEALWELL’s subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL’s Polyclinic Family and Specialty Medicine Facility. ...
Toronto, ON, June 13 - BioPharma Services is thrilled to announce that HEALWELL AI signed a share purchase agreement with Think Research on June 13, 2024, to acquire BioPharma Services. HEALWELL AI, with WELL Health Technologies Corp. (TSX: WELL) as its largest...
Toronto, Canada, May 7, 2024 - BioPharma Services, a leading contract research organization specializing in early clinical trials, is pleased to announce that it has been awarded a groundbreaking First-in-Human (FIH) study. This milestone follows a significant...
[TORONTO, July 17, 2023] — BioPharma Services, a leading Clinical Research Organization (CRO) globally renowned for advancing healthcare through clinical studies, recently completed a comprehensive inspection conducted by the World Health Organization (WHO) and Health...
